Clinical insomnia and associated factors in failed back surgery syndrome: a retrospective cross-sectional study by 源��떊�삎 et al.
Int. J. Med. Sci. 2017, Vol. 14 
 
 
http://www.medsci.org 
536 
International Journal of Medical Sciences 
2017; 14(6): 536-542. doi: 10.7150/ijms.18926 
Research Paper 
Clinical insomnia and associated factors in failed back 
surgery syndrome: a retrospective cross-sectional study 
Soon Young Yun, Do Heon Kim, Hae Yoon Do, and Shin Hyung Kim 
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea  
 Corresponding author: Shin Hyung Kim MD, PhD., Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei 
University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea Tel: 82-2-2228-7500, Fax: 82-2-364-2951, E-mail: tessar@yuhs.ac 
© Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license 
(https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. 
Received: 2016.12.26; Accepted: 2017.03.15; Published: 2017.04.09 
Abstract 
Background Insomnia frequently occurs to patients with persistent back pain. By worsening pain, 
mood, and physical functioning, insomnia could lead to the negative clinical consequences of 
patients with failed back surgery syndrome (FBSS). This retrospective and cross-sectional study 
aims to identify the risk factors associated with clinical insomnia in FBSS patients.  
Methods A total of 194 patients with FBSS, who met the study inclusion criteria, were included in 
this analysis. The Insomnia Severity Index (ISI) was utilized to ascertain the presence of clinical 
insomnia (ISI score ≥ 15). Logistic regression analysis evaluates patient demographic factors, 
clinical factors including prior surgical factors, and psychological factors to identify the risk factors 
of clinical insomnia in FBSS patients.  
Results After the persistent pain following lumbar spine surgery worsened, 63.4% of patients 
reported a change from mild to severe insomnia. In addition, 26.2% of patients met the criteria for 
clinically significant insomnia. In a multivariate logistic regression analysis, high pain intensity (odds 
ratio (OR) =2.742, 95% confidence interval (CI): 1.022 – 7.353, P=0.045), high pain catastrophizing 
(OR=4.185, 95% CI: 1.697 – 10.324, P=0.002), greater level of depression (OR =3.330, 95% CI: 
1.127 – 9.837, P=0.030) were significantly associated with clinical insomnia. However, patient 
demographic factors and clinical factors including prior surgical factors were not significantly 
associated with clinical insomnia.  
Conclusions Insomnia should be addressed as a critical part of pain management in FBSS patients 
with these risk factors, especially in patients with high pain catastrophizing. 
Key words: failed back surgery syndrome; insomnia; risk factors; pain severity; depression; pain 
catastrophizing. 
Introduction 
Failed back surgery syndrome (FBSS), also called 
post-laminectomy syndrome, is a term that defines an 
unsatisfactory result of a patient who suffered from 
spinal surgery regardless of the type and intervention 
area [1]. FBSS is associated with chronic pain in the 
lumbosacral area with or without radiation to the leg 
[1]. This can give rise to persistent pain and disability 
which often impose serious emotional and financial 
burden on the patient [2]. 
Insomnia has long been known to be related to 
chronic pain conditions. Insomnia is caused by 
reduced sleep quality and duration, a greater amount 
of time of fall asleep, poor daytime function, and 
greater sleep dissatisfaction and distress [3]. A study 
has recently reported that a significantly high 
prevalence of sleep deprivation was found in patients 
with FBSS [4]. Because insomnia has been shown to 
worsen pain, mood, and physical functioning, it could 
negatively impact the clinical outcomes of patients 
with FBSS. Thus, identifying subgroups of the FBSS 
population with a high risk for insomnia has a clinical 
importance. Understanding these factors will help 
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clinicians educate patients and will facilitate the 
formulation of more effective treatment plans. 
However, many clinics have insufficient resources or 
expertise that provide a detailed sleep assessment for 
FBSS patients who are complaining of insomnia.  
The Insomnia Severity Index (ISI) is a self-report 
measure to assess patient’s perception of insomnia 
and the levels of severity [5]. The index is comprised 
of seven items of the subjective symptoms and 
daytime outcomes of insomnia along with the degree 
of distress that those difficulties cause. The 
questionnaire is brief and easy to score. Also, the ISI 
has demonstrated useful psychometric properties: 
convergent validity, discriminant validity, and 
test-retest reliability [5].  
The aim of this retrospective and cross-sectional 
study is to identify factors relevant to clinical 
insomnia based on ISI scores in FBSS patients among 
demographic factors, clinical factors including prior 
surgical factors, and psychological factors.  
Methods 
Study population 
The institutional review board approved this 
retrospective and cross-sectional study. In this study, 
the sample population was patients with FBSS, who 
were treated for pain between January and December 
2015 at our outpatient clinic. Data was obtained from 
a clinical data retrieval system in our institution. For 
this study, we defined FBSS as persistent or recurrent 
back and/or leg pain that occur notwithstanding 
lumbar (open) spinal surgery [1]. Patients who 
received their last surgery ≥3 months before the start 
of this study were included. The persistence of pain 
beyond 3 months established chronicity. We did not 
include patients who underwent percutaneous pain 
interventions such as epidural neuroplasty. We 
excluded patients with current infectious diseases, 
cancer, and psychiatric and neurologic disorders that 
would preclude completion of pain-related 
questionnaires. Patients were also excluded if they 
had major structural pathologies of the lumbar spine 
including traumatic spinal cord injuries, infections, or 
neoplasms. In addition, patients who were reported to 
have been diagnosed with primary insomnia or with 
obstructive sleep apnea or peripheral neuropathy 
were excluded.  
Insomnia severity measurement 
The severity and prevalence of insomnia were 
assessed by using the ISI data which was recorded at 
the first visit. The ISI includes seven items that assess 
severity of sleep onset, sleep-maintenance difficulties, 
patient satisfaction with current sleep pattern, 
insomnia interference with daily functioning, 
noticeable impairment of abilities attributed to sleep 
deprivation, and the degree of distress caused by 
sleep problem. Each item is graded on a five-point 
scale (0 to 4), so that the global score range from 0 to 
28, with higher scores indicating more severe 
insomnia. According to the recommended score 
interpretation guidelines [5], a global score of 0-7 
indicates “no clinically significant insomnia,” 8-14 
indicates “sub-threshold insomnia,” 15-21 indicates 
“moderate clinical insomnia,” and 22-28 indicates 
“severe clinical insomnia.” For this study, we defined 
clinical insomnia as an ISI global score ≥15. 
Data measures and assessments 
Patient data on age, gender, body mass index 
(BMI), duration of pain, pain score measured on a 0 to 
10 numeric rating scale (NRS; we asked patients to 
rate their worst back and/or leg pain that they felt 
during the last 2 weeks), current medications, 
presence of medical comorbidities (diagnosed 
hypertension, diabetes mellitus, heart diseases, or 
neurologic diseases currently requiring medical 
treatment), detailed lumbar spinal surgical history 
(number of prior surgery and type of surgery), 
presence of pain-related compensation (workers’ 
compensation patients and those involved in 
accidents with insurance coverage/involvement), 
presence of symptoms suggesting neuropathic pain 
(radiating pain and/or symptoms including 
dysesthesia or allodynia, burning or coldness, “pins 
and needles” sensation, numbness and itching), and 
presence of comorbid musculoskeletal pain 
(musculoskeletal pain in areas other than the back and 
legs, such as the neck, shoulder, or joints), and level of 
anxiety or depression as assessed by the 14 items on 
the Hospital Anxiety and Depression Scale (HADS) 
[6]. The 14 HADS items, each scored on a 0 to 3 scale, 
were used to measure degree of anxiety (seven items) 
and depression (seven items). Thus, the two subscales 
range from 0 to 21, with higher scores indicating a 
greater likelihood of an anxiety or depressive 
disorder. The cut-off value for identification of 
suspected cases is generally considered to be 8 [6]. The 
severity of pain catastrophizing was evaluated by 
using the Pain Catastrophizing Scale (PCS). The PCS 
is comprised of 13 items measuring catastrophizing 
thoughts or feelings accompanying the experience of 
pain. We ask respondents to reflect their past painful 
experiences and to indicate to what degree of 13 
thoughts or feelings they were experienced when in 
pain. Each item is graded on a five-point scale (0=not 
at all to 4=all the time), so the global score ranges from 
0 to 52, with higher scores indicating a greater pain 
catastrophizing state [7]. The cut-off value for 
identification of high risk cases is generally 
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considered to be 30 [7]. The demographic data and 
pain-related clinical data, ISI, HADS, and PCS data 
were obtained from all patients by independent 
resident doctors during the preliminary medical 
examination. 
Statistical Analysis 
Continuous variables as mean ± SD, and 
categorical variables as numbers (percentage) are 
shown to us. Logistic regression was utilized to 
estimate crude odds ratios (ORs) with 95% confidence 
intervals (CIs) to determine the degree of correlation 
between candidate effect variables and clinical 
insomnia (ISI score ≥15). The analyzed variables 
included demographic data (age, gender, BMI), 
duration of pain (<1 year or ≥1 year), pain score (NRS 
<7 or ≥7), presence of comorbidities, multiple prior 
spinal surgery, type of spinal surgery, presence of a 
neuropathic pain component, presence of comorbid 
musculoskeletal pain, severity of anxiety and 
depression symptoms (HADS <8 or ≥8), and severity 
of pain catastrophizing (PCS <30 or ≥ 30). Variables 
with a P-value <0.05 were considered to be 
statistically significant and were included in a 
multivariate logistic regression analysis to estimate 
adjusted ORs and 95% CIs. All statistical analyses 
were performed using the Statistical Package for the 
Social Sciences, version 23.0 (SPSS Inc., Chicago, IL, 
USA). 
Results 
Data from 229 patients with prior lumbar spinal 
surgery history who were treated for back/ leg pain at 
our pain clinic were acquired from electronic medical 
records. After excluding cases of patients who had 
received surgery within 3 months before the study, 
patients in total were assessed for eligibility. Five 
patients with cancer and four patients with 
pre-existing psychiatric and neurologic disorders 
such as major depressive disorder and Alzheimer’s 
disease were excluded. Two patients who were 
suspected to have had diabetic neuropathy and one 
patient with traumatic spinal cord injury were 
excluded. Four patients were excluded for primary 
insomnia that emerged prior to pain. Seven patients 
with incomplete data were also excluded. Finally, a 
total of 194 patients with FBSS satisfied the study 
inclusion criteria and were included in the analyses 
(Figure 1). 
 
 
 
Figure 1. Flow chart of the study. ISI= Insomnia Severity Index. 
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Table 1 shows patient demographics and clinical 
characteristics. Most patients suffered from adjacent 
segment diseases such as recurred disc herniation, 
stenosis, and instability in adjacent segments. Also, 
suspected causes of pain were very mixed in that 66% 
of patients had more than two types of suspected 
diagnoses. The mean global score for the ISI was 9.4, 
and 63.4% of patients reported from mild to severe 
insomnia symptoms (ISI score ≥ 8) after their pain 
development. In 26.2% of patients, clinical insomnia 
with moderate to severe severity (ISI score ≥ 15) was 
observed (Table 2).  
 
Table 1. Demographics and clinical characteristics 
 n=194 
Age, years 65.0 ± 12.2 (26-84) 
Gender, M/F 81/113 
Body mass index, kg/m2 24.9 ± 3.1 (16.0-34.9) 
Pain duration, months 31.9 ± 47.3 (3 months-20 years) 
Pain score, 0 to 10 NRS 6.6 ± 2.2 (1-10) 
Type of prior surgery, n  
 Fusion 77 (39.6%) 
 Laminectomy 89 (45.8%) 
 Discectomy  39 (20.1%) 
 Other  25 (12.8%) 
Diagnosis, n  
 Recurrent disc herniation*  42 (21.6%) 
 Canal/foraminal stenosis*   68 (35.0%) 
 Epidural fibrosis/adhesions*  16 (8.2%) 
 Spinal instability/pseudarthrosis  21 (10.8%) 
 Facet/sacroiliac joint pain   47 (24.2%) 
 Myofascial pain   28 (14.4%) 
 Surgical complications   3 (1.5%) 
 Other   12 (6.1%) 
Values are expressed as the mean ± SD (range) or number of patients (%). 
NRS=numeric rating scale. *Diagnosed via MRI  
Table 2. Insomnia Severity Index score data  
 n=194 
Global score of the Insomnia Severity Index 9.43 ± 5.84 (2-25) 
Severity of insomnia  
 0-7: no insomnia 71 (36.6%) 
 8-14: sub-threshold insomnia 72 (37.1%) 
 15-21: clinical insomnia (moderate) 45 (23.2 %) 
 22-28: clinical insomnia (severe) 6 (3.1%) 
Values are expressed as the mean ± SD (range) or number of patients (%). 
 
 
We found in univariate analysis that a high pain 
score (NRS ≥ 7), the presence of pain-related 
compensation, a high level of pain catastrophizing 
(PCS ≥ 30), and a greater level of anxiety and 
depression (HADS ≥ 8) were all significantly related 
to clinical insomnia (Table 3). There were no 
noteworthy differences in demographic factors such 
as age, gender, and BMI between patients who 
reported clinical insomnia and those who did not. 
Surgery-related factors such as multiple prior surgery 
history and fusion surgery showed no significant 
association with clinical insomnia.  
Multivariate logistic regression analysis showed 
that a high pain score (NRS ≥ 7), a high pain 
catastrophizing level (PCS ≥ 30), and a greater level of 
depression (HADS ≥ 8) were deeply affected by 
clinical insomnia in our study population (Table 3). 
Among the above-mentioned variables, high pain 
catastrophizing (PCS ≥ 30) was the strongest factor 
associated with clinical insomnia, having the highest 
odds ratio of 4.185 (95% CI 1.697 – 10.324).  
 
 
Table 3. Crude and adjusted odds ratios for factors associated with clinical insomnia (Insomnia Severity Index ≥15) in 194 patients with 
failed back surgery syndrome: results of logistic regression analysis 
Factors  n  Clinical insomnia, n (%) Crude OR (95% CI) P-value Adjusted OR (95% CI) P-value 
Demographic factors       
Gender    0.923  0.815 
 Male 81 21 (25.9) 1.000  1.000  
 Female 113 30 (26.5) 1.033 (0.540 – 1.976)  1.109 (0.466 – 2.637)  
Age    0.162  0.738 
 < 65 years 79 25 (31.6) 1.000  1.000  
 ≥65 years 115 26 (22.6) 0.631 (0.331 –1.202)  0.865 (0.369-2.024)  
Body mass index     0.284   
 ＜25 kg/m2 115 27 (23.4) 1.000    
 ≥25 kg/m2 79 24 (30.3) 1.422 (0.746 – 2.710)    
Clinical factors       
Pain duration    0.993   
 <1 year 99 26 (26.2) 1.000    
 ≥1 year 95 25 (26.3) 1.003 (0.529 – 1.901)    
Pain score    < 0.001  0.045 
 <7 NRS 77 8 (10.3) 1.000  1.000  
 ≥7 NRS 117 43 (36.7) 5.012 (2.201 – 11.412)  2.742 (1.022 – 7.353)  
Comorbidities    0.422   
 No 62 14 (22.5) 1.000    
 Yes 132 37 (28.0) 1.335 (0.659 – 2.706)    
Multiple prior spinal surgery    0.345   
 No 150 37 (24.6) 1.000    
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 Yes 44 14 (31.8)  1.425 (0.683 – 2.972)    
Fusion surgery     0.114   
 No 117 26 (22.2) 1.000    
 Yes 77 25 (32.4) 1.683 (0.882 – 3.211)    
 Comorbid musculoskeletal pain 
(except back and legs)  
   0.688   
 No 160 43 (26.8) 1.000    
 Yes 34 8 (23.5) 0.837 (0.352 – 1.991)    
Neuropathic pain components     0.478   
 No 41 9 (21.9) 1.000    
 Yes 153 42 (27.4) 1.345 (0.592 – 3.056)    
Compensation/legal claims    < 0.001  0.121 
 No 178 42 (23.5) 1.000  1.000  
 Yes 16 9 (56.2) 4.163 (1.462 – 11.856)  2.950 (0.751 – 11.583)  
Psychological factors       
Pain catastrophizing     < 0.001  0.002 
 ＜30 PCS  144 19 (13.1) 1.000  1.000  
 ≥30 PCS 50 32 (64.0) 11.696 (5.511 – 24.824)  4.185 (1.697 – 10.324)  
Anxiety    < 0.001  0.143 
 ＜8 HADS-A 140 20 (14.2) 1.000  1.000  
 ≥8 HADS-A 54 31 (57.4) 8.087 (3.946 – 16.575)  2.204 (0.766 – 6.336)  
Depression    < 0.001  0.030 
 ＜8 HADS-D 143 20 (13.9) 1.000  1.000  
 ≥8 HADS-D 51 31 (60.7) 9.532 (4.574 – 19.867)  3.330 (1.127 – 9.837)  
Significant variables (P < 0.05) in univariate analysis were selected for multivariate analysis. Age and gender were included in the multivariate analysis because these have 
been identified as demographic risk factors for insomnia in the general population [3]. OR = odds ratio; CI = confidence interval; NRS = numeric rating scale; PCS = Pain 
Catastrophizing Scale; HADS = Hospital Anxiety and Depression Scale 
 
Discussion 
In the present study, our findings confirmed that 
insomnia is common in FBSS patients. We found that 
high pain intensity, high pain catastrophizing, and 
high depression were strongly associated with severe 
insomnia symptoms in FBSS patients. However, 
patient demographic factors and clinical factors 
including prior surgical factors were connected 
insignificantly with clinical insomnia in this 
population. 
Most previous studies similarly pointed out that 
high pain intensity is crucially linked with insomnia 
in chronic pain patients [4, 8-10]. In addition to this, a 
bidirectional relationship between pain and sleep was 
also reported as relating to chronic pain [11]. Sleep 
disturbances appear to have increased pain through 
hyperalgesia and decreased ability to bear pain 
[12-14]. This association between sleep deprivation 
and persistent pain could be explained by brain 
structure. For instance, the periaqueductal gray region 
and thalamus are known to play key roles in sleep 
and nociception [15-18]. A recent interesting study 
demonstrated that spinal cord stimulation for FBSS 
treatment makes better sleep and this sleep 
improvement correlates with better pain relief [19]. As 
a contributor to pain, insomnia should be 
incorporated in treatment planning for the pain 
associated with FBSS.  
In this study, pain catastrophizing appeared to 
be the strongest risk factor for clinical insomnia in 
FBSS patients. This result indicates that cognitive 
processes related to pain may play a key role in 
insomnia development/severity in the population. 
Catastrophizing is defined as an exaggerated negative 
mindset to endure actual or anticipated painful 
experiences [20]. It is a key factor in what way 
cognition, beliefs, coping strategies and functioning 
are associated with the experience of pain [21]. 
Catastrophizing negatively influenced the prognosis 
of pain and disability in patients with chronic low 
back pain [22]. Although few studies address how 
pain catastrophizing plays in the connection between 
insomnia and pain, an important portion of variation 
in clinical pain severity is attributable to pain 
catastrophizing, and particularly rumination about 
pain was mediated by sleep disturbances in a 
population suffering from chronic myofascial pain 
[23]. Patients with osteoarthritis, comorbid insomnia 
and a high level of catastrophizing reported increased 
clinical pain following increased levels of central 
sensitization [24]. Collectively, pain catastrophizing 
should be considered in the sleep-pain relationship, 
although the underlying cognitive processes in 
comorbid insomnia and chronic pain are not yet clear 
[25]. 
In this study, a greater level of depression 
appeared to be a risk factor for clinically important 
insomnia in FBSS patients. Patients with FBSS 
frequently suffered from poor psychological states, 
such as depression [26]. Patients with long-lasting 
pain with concurrent major depression and insomnia 
showed severe pain-related psychosocial impairment 
[27]. Also, depression and sleep disturbance are 
independently associated with a reduced pain 
threshold [28]. According to the criteria in the 
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Diagnostic and Statistical Manual of Mental 
Disorders, insomnia is a defining symptom of major 
depressive disorder [27]. Thus, insomnia has 
traditionally been assumed to be simply a comorbid 
symptom of depression, and has not been recognized 
as a separate disorder. However, recent studies 
suggest that insomnia may be independent of pain 
and depression in chronic pain patients [27-29]. Thus, 
FBSS patients with depression are highly susceptible 
to insomnia, and insomnia may be considered a 
separate symptom when devising treatment strategies 
for this subgroup, which is more prone to poor clinical 
outcomes. 
In the general adult population, age and gender 
are confirmed demographic risk factors for insomnia, 
with a greater prevalence in women and older adults 
[3]. However, in chronic pain conditions, pain-related 
clinical characteristics seem to be more important than 
patient demographics in insomnia. Patient 
demographic factors were not significantly associated 
with clinical insomnia in patients with FBSS in this 
study. In several studies dealing with insomnia in 
chronic pain as well as our study, no relationship 
between insomnia and age, gender, or BMI was 
reported [4, 8, 9].  
Before the study, we expected that surgical 
factors, such as multilevel fusion surgery or multiple 
prior surgery history, might influence sleep in the 
FBSS population. However, we observed a lack of 
significance between prior surgical history and 
current insomnia severity in this population. Our 
results showed that current pain severity and poor 
psychological states may contribute more to clinical 
insomnia than prior surgical history in this 
population. The presence of pain-related 
compensation was significantly associated with 
clinical insomnia in FBSS on univariate analysis. In 
fact, a significant number of FBSS patients are 
concerned in workman’s compensation or personal 
injury lawsuits [2]. Patients in workman’s 
compensation tend to have worse lumbar fusion 
consequences and lower postoperative return to work 
rates [30, 31]. However, there is not currently any 
clinical literature that discusses the sleep-pain 
relationship in workman’s compensation patients 
with FBSS. In this study, the number of patients was 
not sufficient to unequivocally demonstrate an 
association between insomnia and compensation. 
Thus, more studies are required to evaluate the 
sleep-pain relationship in workman’s compensation 
patients with FBSS. 
Our study has some limitations. First, the study 
was managed in a single clinical setting that includes 
a selected study population with a homogeneous 
racial background. Thus, one must be cautious when 
generalizing these results to other populations. 
Second, use of a cross-sectional study limits the ability 
to make causal inferences between insomnia and 
current pain or sleep treatments. Also, the ISI does not 
include detailed parameters on the frequency or 
duration of insomnia and medication use, which 
could influence the severity of insomnia. Finally, this 
study was based on the subjective assessment of 
insomnia. Although the ISI has obvious advantages 
over other available measurements of insomnia in 
busy clinical settings, it seems important to include 
objective assessments of sleep with 
polysomnographic or actigraphic evidence [32].  
In conclusion, our results demonstrated that pain 
intensity, pain catastrophizing, and depression were 
significantly associated with clinical insomnia in FBSS 
patients. Insomnia should be addressed as a critical 
part of pain management in FBSS patients with these 
risk factors, especially in patients with high pain 
catastrophizing. 
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